Does comorbid disruptive behavior modify the effects of atomoxetine on ADHD symptoms as measured by a continuous performance test and a motion tracking device?

Objective: To compare the reduction of ADHD symptoms under atomoxetine in patients with and without comorbid oppositional defiant disorder (ODD) or conduct disorder (CD) using a computer-based continuous performance test (cb-CPT) combined with an infrared motion tracking (MT) device. Method: Seconda...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wehmeier, Peter M. (VerfasserIn) , Banaschewski, Tobias (VerfasserIn) , Dittmann, Ralf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2015
In: Journal of attention disorders
Year: 2015, Jahrgang: 19, Heft: 7, Pages: 591-602
ISSN:1557-1246
DOI:10.1177/1087054712456739
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1177/1087054712456739
Verlag, Volltext: https://doi.org/10.1177/1087054712456739
Volltext
Verfasserangaben:Peter M. Wehmeier, Laura Kipp, Tobias Banaschewski, Ralf W. Dittmann, and Alexander Schacht

MARC

LEADER 00000caa a2200000 c 4500
001 1571091467
003 DE-627
005 20220814093336.0
007 cr uuu---uuuuu
008 180315s2015 xx |||||o 00| ||eng c
024 7 |a 10.1177/1087054712456739  |2 doi 
035 |a (DE-627)1571091467 
035 |a (DE-576)501091467 
035 |a (DE-599)BSZ501091467 
035 |a (OCoLC)1340994367 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wehmeier, Peter M.  |d 1963-  |e VerfasserIn  |0 (DE-588)112354939  |0 (DE-627)503816221  |0 (DE-576)289728894  |4 aut 
245 1 0 |a Does comorbid disruptive behavior modify the effects of atomoxetine on ADHD symptoms as measured by a continuous performance test and a motion tracking device?  |c Peter M. Wehmeier, Laura Kipp, Tobias Banaschewski, Ralf W. Dittmann, and Alexander Schacht 
264 1 |c 2015 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.03.2018 
520 |a Objective: To compare the reduction of ADHD symptoms under atomoxetine in patients with and without comorbid oppositional defiant disorder (ODD) or conduct disorder (CD) using a computer-based continuous performance test (cb-CPT) combined with an infrared motion tracking (MT) device. Method: Secondary analysis of a placebo-controlled study in ADHD patients (6-12 years old) treated with atomoxetine (target dose: 1.2 mg/kg per day). Cb-CPT/MT scores were analyzed using ANCOVA (last observation carried forward [LOCF]). Results: The data (N = 125) suggested a more pronounced atomoxetine effect in the group with comorbid ODD/CD as measured by all cb-CPT/MT parameters except for “normalized variation of reaction time” (nVRT). Conclusion: The results showed that atomoxetine reduced ADHD severity as measured by cb-CPT and MT parameters regardless of whether comorbid ODD/CD was present. The treatment effect of atomoxetine on hyperactivity appears to be more pronounced in the subgroup of patients with comorbid ODD/CD than in the subgroup without this comorbidity. 
700 1 |a Banaschewski, Tobias  |d 1961-  |e VerfasserIn  |0 (DE-588)115856110  |0 (DE-627)507227301  |0 (DE-576)178364703  |4 aut 
700 1 |a Dittmann, Ralf  |e VerfasserIn  |0 (DE-588)1032941170  |0 (DE-627)739784323  |0 (DE-576)38041337X  |4 aut 
773 0 8 |i Enthalten in  |t Journal of attention disorders  |d Thousand Oaks, Calif. : Sage, 1996  |g 19(2015), 7, Seite 591-602  |h Online-Ressource  |w (DE-627)487889622  |w (DE-600)2188086-4  |w (DE-576)276559177  |x 1557-1246  |7 nnas  |a Does comorbid disruptive behavior modify the effects of atomoxetine on ADHD symptoms as measured by a continuous performance test and a motion tracking device? 
773 1 8 |g volume:19  |g year:2015  |g number:7  |g pages:591-602  |g extent:12  |a Does comorbid disruptive behavior modify the effects of atomoxetine on ADHD symptoms as measured by a continuous performance test and a motion tracking device? 
856 4 0 |u http://dx.doi.org/10.1177/1087054712456739  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.1177/1087054712456739  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180315 
993 |a Article 
994 |a 2015 
998 |g 1032941170  |a Dittmann, Ralf  |m 1032941170:Dittmann, Ralf  |d 60000  |e 60000PD1032941170  |k 0/60000/  |p 4 
998 |g 115856110  |a Banaschewski, Tobias  |m 115856110:Banaschewski, Tobias  |d 60000  |e 60000PB115856110  |k 0/60000/  |p 3 
998 |g 112354939  |a Wehmeier, Peter M.  |m 112354939:Wehmeier, Peter M.  |d 60000  |e 60000PW112354939  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1571091467  |e 3003446274 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Peter M. Wehmeier, Laura Kipp, Tobias Banaschewski, Ralf W. Dittmann, and Alexander Schacht"]},"id":{"doi":["10.1177/1087054712456739"],"eki":["1571091467"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}],"relHost":[{"title":[{"title":"Journal of attention disorders","title_sort":"Journal of attention disorders"}],"origin":[{"publisherPlace":"Thousand Oaks, Calif.","publisher":"Sage","dateIssuedKey":"1996","dateIssuedDisp":"1996-"}],"id":{"issn":["1557-1246"],"zdb":["2188086-4"],"eki":["487889622"]},"pubHistory":["1.1996 -"],"part":{"issue":"7","pages":"591-602","year":"2015","extent":"12","volume":"19","text":"19(2015), 7, Seite 591-602"},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Does comorbid disruptive behavior modify the effects of atomoxetine on ADHD symptoms as measured by a continuous performance test and a motion tracking device?Journal of attention disorders","physDesc":[{"extent":"Online-Ressource"}],"recId":"487889622","language":["eng"]}],"physDesc":[{"extent":"12 S."}],"person":[{"roleDisplay":"VerfasserIn","display":"Wehmeier, Peter M.","role":"aut","family":"Wehmeier","given":"Peter M."},{"roleDisplay":"VerfasserIn","display":"Banaschewski, Tobias","role":"aut","family":"Banaschewski","given":"Tobias"},{"role":"aut","display":"Dittmann, Ralf","roleDisplay":"VerfasserIn","given":"Ralf","family":"Dittmann"}],"title":[{"title_sort":"Does comorbid disruptive behavior modify the effects of atomoxetine on ADHD symptoms as measured by a continuous performance test and a motion tracking device?","title":"Does comorbid disruptive behavior modify the effects of atomoxetine on ADHD symptoms as measured by a continuous performance test and a motion tracking device?"}],"recId":"1571091467","language":["eng"],"note":["Gesehen am 15.03.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a WEHMEIERPEDOESCOMORB2015